Stay updated on Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial page.

Latest updates to the Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe ClinicalTrials.gov site footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check17 days agoChange DetectedA sitewide NIH notice announces a transition from using the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference0.8%

- Check24 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check31 days agoChange DetectedThe site revision label changed from `v3.7.0` to `v3.7.1`.SummaryDifference0.1%

- Check52 days agoChange DetectedA new revision v3.7.0 was added to the study's history and the previous revision v3.6.6 was removed from the history, updating the version log.SummaryDifference0.1%

- Check73 days agoChange DetectedNew record revision v3.6.6 was added to the history, and the previous revision v3.6.5 was removed. This updates the study's version history.SummaryDifference0.1%

Stay in the know with updates to Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial page.